Profil
Michael F.
Snape is the founder of AMO Pharma Ltd.
(founded in 2015) and holds the title of Chief Scientific Officer.
Dr. Snape is also the founder of Neuropharm Group Plc.
Aktive Positionen von Michael F. Snape
| Unternehmen | Position | Beginn |
|---|---|---|
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Michael F. Snape
| Unternehmen | Position | Ende |
|---|---|---|
Neuropharm Group Plc
 Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Gründer | 12.07.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Neuropharm Group Plc develops and manufactures speciality pharmaceuticals. It develops medicines for the treatment and management of neurodevelopmental disorders. The company was founded by Dr. Michael Snape and is headquartered in Leatherhead, the United Kingdom. | Health Technology |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
